| |
| |
|
| Insider
Information: |
Hugin Robert J |
| Relationship: |
|
| City: |
Warren |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,094,621 |
|
|
Indirect Shares
|
10,576 |
|
|
| Direct
Value |
$120,630,131 |
|
|
|
Indirect Value
|
$1,191,747 |
|
|
| Total
Shares |
1,105,197 |
|
|
| Total
Value |
$121,821,878 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celgene Corp |
CELG |
see remarks, Director |
2017-10-26 |
1,060,106 |
2017-10-26 |
10,241 |
Premium* |
|
|
Danaher Corp |
DHR |
Director |
2017-05-15 |
3,576 |
2016-07-15 |
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2019-02-18 |
0 |
Premium* |
|
|
Chubb Ltd (ACE Ltd) |
CB |
Director |
2023-05-17 |
17,980 |
2023-05-17 |
335 |
Premium* |
|
|
Biohaven Ltd. |
BHVN |
|
2022-10-03 |
12,959 |
2022-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
121 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGN |
Allergan plc |
Director |
– • – |
2019-02-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2019-02-18 |
4 |
A |
$139.07 |
$59,244 |
D/D |
426 |
3,426 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2019-04-30 |
4 |
D |
$147.00 |
$30,135 |
D/D |
(205) |
3,221 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2019-05-02 |
4 |
A |
$145.33 |
$299,961 |
D/D |
2,064 |
5,285 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2020-05-01 |
4 |
D |
$189.74 |
$391,623 |
D/D |
(2,064) |
4,294 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,294) |
0 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,158 |
3,158 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4/A |
D |
$7.50 |
$97,193 |
D/D |
(12,959) |
12,959 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
D |
$7.50 |
$24,473 |
D/D |
(3,263) |
19,486 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
OE |
$3.39 |
$73,406 |
D/D |
19,591 |
22,749 |
0 |
- |
|
| CB |
Chubb Ltd (ACE Ltd) |
Director |
– • – |
2020-05-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
% |
|
| CB |
Chubb Ltd (ACE Ltd) |
Director |
– • – |
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,916 |
12,916 |
0 |
- |
|
| CB |
Chubb Ltd (ACE Ltd) |
Director |
– • – |
2020-05-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
335 |
|
% |
|
| CB |
Chubb Ltd (ACE Ltd) |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,836 |
14,752 |
0 |
- |
|
| CB |
Chubb Ltd (ACE Ltd) |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,594 |
16,346 |
0 |
- |
|
| CB |
Chubb Ltd (ACE Ltd) |
Director |
– • – |
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,634 |
17,980 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-07-22 |
4 |
OE |
$5.21 |
$99,999 |
D/D |
19,200 |
108,425 |
|
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-11-02 |
4 |
S |
$30.73 |
$2,765,574 |
D/D |
(90,000) |
126,850 |
|
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-11-03 |
4 |
OE |
$5.50 |
$90,198 |
D/D |
11,360 |
140,660 |
|
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-11-03 |
4 |
OE |
$5.51 |
$250,430 |
D/D |
45,450 |
129,300 |
|
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-11-03 |
4 |
S |
$31.30 |
$1,345,827 |
D/D |
(43,000) |
83,850 |
|
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-12-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
7,400 |
133,260 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2004-12-30 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,400 |
2,400 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2005-02-28 |
4 |
OE |
$8.82 |
$882,500 |
D/D |
100,000 |
233,260 |
|
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• • – |
2005-09-02 |
4 |
OE |
$8.83 |
$6,028,016 |
D/D |
427,300 |
427,317 |
|
- |
|
121 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
